Trial Profile
A phase I Pharmacokinetic study of AG-013 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Sep 2016
Price :
$35
*
At a glance
- Drugs Dapatifagene navolactibac (Primary)
- Indications Stomatitis
- Focus Pharmacokinetics
- 19 Sep 2016 New trial record